Recombinant Human Serum Albumin Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Albumedix, Merck, Ventria (InVitria), NCPC

The global Recombinant Human Serum Albumin market size is expected to grow at US$ 125.42 million in 2027 at a compound annual growth rate (CAGR) of 8.9%.

Recombinant Human Serum Albumin Market Overview

Albumins are a type of acidic protein found in human physiological fluids as well as plant and mammalian tissues. This protein's main job is to control the blood's colloidal osmotic pressure. Albumin is a protein that the human body produces in the liver and then diffuses into the bloodstream where it controls blood volume and transports molecules like ions, hormones, and bile salts. Bovine serum albumin, recombinant albumin, and human serum albumin are the three main kinds of albumin. Recombinant human serum albumin is in high demand due to its major use in restoring lost fluid and assisting in the restoration of blood volume during serious burn injuries, neonatal erythroblastosis, hypoproteinemia, surgeries, and other conditions. Due to its hydrophobic characteristics, recombinant human serum albumin exhibits an excellent ability to transport different ligands. As a result, product demand for drug delivery applications has surged. Additionally, it is used therapeutically to address low albumin levels brought on by dialysis, surgery, gastrointestinal infections, pancreatitis, liver failure, respiratory distress, ovarian abnormalities brought on by fertility medicines, bypass surgery, and other medical illnesses. The product's extensive use in medicine is expected to increase the market share for recombinant human serum albumin. Millions of people are inoculated each year using cell culture-based vaccinations, and millions more are treated for various ailments with cell culture-based therapies. Over the projection term, this could significantly increase revenue share. The expansion of the sector will also benefit from advancements in protein purification and molecular separation technologies.

Industry News and Updates:

July 27, 2022: REGENERON GENETICS CENTER DISCOVERS RARE MUTATIONS IN THE CIDEB GENE THAT PROTECT AGAINST LIVER DISEASE --

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that scientists from the Regeneron Genetics Center® (RGC) have uncovered rare genetic loss-of-function mutations in the CIDEB gene that are associated with substantial protection from liver disease, including serious diseases such as nonalcoholic steatohepatitis (NASH) and cirrhosis. The new discovery has been published today in The New England Journal of Medicine.

What are the major Applications, Types and Regions for Recombinant Human Serum Albumin Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• OsrHSA


• ScrHSA

By Application, it is segmented into

• Cell Culture Media


• Medical Supplements


• Others

Recombinant Human Serum Albumin Market Regional Analysis

North America was the largest revenue contributor to the global recombinant human serum albumin market in 2019 and is predicted to show substantial growth through 2027 due to an increase in albumin product approvals as well as a favourable medical research scenario in the area. However, due to a rise in healthcare spending and rising awareness of the use of DNA recombinant technology for treatment, Asia-Pacific is predicted to have the highest CAGR throughout the analysed period.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Recombinant Human Serum Albumin Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Recombinant Human Serum Albumin Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Recombinant Human Serum Albumin Market report scope?

Key Takeaways from this Recombinant Human Serum Albumin Market Report

• Evaluate Recombinant Human Serum Albumin market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Recombinant Human Serum Albumin market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Recombinant Human Serum Albumin Market?

The Recombinant Human Serum Albumin Market is growing at a CAGR of 8.9% over the next 5 years.

Who are the key players in Recombinant Human Serum Albumin Market?

Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia, Boehringer Ingelheim, Regeneron Pharmaceuticals, Eli Liily, Bristol-Myers Squibb, Novartis, Celldex Therapeutics, Takeda, GlaxoSmithKline, Roche, Cyagen Biosciences

What are the significant types of Recombinant Human Serum Albumin Market?

OsrHSA, ScrHSA

What are the major end-use applications of Recombinant Human Serum Albumin Market?

Cell Culture Media, Medical Supplements, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.